All News

Ruth M Carrico, PhD, DNP, APRN, discusses the significance of the FLUBLOK vaccine's updated label, offering pregnant patients a safe and effective alternative for influenza prevention.

A recent study shows a significant decrease in primary cytoreductive surgery utilization for advanced ovarian cancer, as neoadjuvant chemotherapy followed by interval cytoreductive surgery gains acceptance for its noninferior survival outcomes and reduced postoperative morbidity.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Following the Dobbs v. Jackson ruling, more women are opting for permanent and long-acting contraceptive methods, even in states where abortion access remains protected.

A recent study found that pregnant patients with multiple unscheduled hospital visits face an increased risk of severe maternal morbidity, emphasizing the need for integrated care responses.

In a recent study, female partners often experienced increased rates of invasive infertility procedures, despite high rates of male-factor infertility.

Sanofi’s influenza vaccine has received an updated label to include adult pregnant women following a trial indicating similar safety outcomes to standard influenza vaccination in this population.

Reunion Neuroscience is enrolling patients in its phase 2 RECONNECT trial to assess a single-dose synthetic psychedelic to treat the depressive symptoms of PPD.

In this 4-part interview, Kingsberg discusses the phase 2 RECONNECT trial assessing RE104 as the potentially first psychedelic to treat postpartum depression.

A new study shows that breast arterial calcification detected on routine mammograms could help predict cardiovascular events such as heart attacks and strokes, particularly in younger women.

In a recent study presented at the 25th Annual Fall Scientific Meeting of SMSNA, similar diagnosing success was reported between self-diagnosis and diagnosis from a health care provider for vaginismus.

Erika Hamilton, MD, discusses concerning increases in breast cancer incidence among younger women and certain ethnic groups, while highlighting new innovations in detection and targeted therapies that offer hope for improved patient outcomes.

In a recent study, mothers and fathers with simultaneous parental leave after birth were more likely to utilize mental health care services than those without simultaneous parental leave.

Elinzanetant, a non-hormonal drug, shows promising results in reducing hot flashes and night sweats, offering a new option for women seeking effective and safe treatment for vasomotor symptoms.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

Research reveals that over a third of adolescents in pediatric emergency departments struggle with access to menstrual products, highlighting the need for improved public health measures.

Despite an increase in mifepristone use to manage early pregnancy loss over time, rates remain low, preventing patients from receiving proven benefits.

In a recent study, multiple reproductive health factors were linked to breast cancer incidence among women in the Caribbean.

In a recent study, similar rates of adverse psychiatric-related outcomes were reported among patients with discontinuation of selective serotonin reuptake inhibitors and serotonin-norepinephrine reuptake inhibitors vs those without discontinuation.

In a recent study, postmenopausal women in lower Tertiles of Estradiol concentration experienced an increased prevalence of abdominal aortic calcification.

In a recent study, approximately half of infective endocarditis cases were women who inject drugs, despite only one-third of people who inject drugs being women.

In a recent study, cardiovascular severe maternal morbidity was significantly more common in patients with hypertensive disorders of pregnancy vs those without.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.

In a recent pilot trial, endometriosis-related visual-analog scale and quality-of-life scores were improved during anakinra treatment cycles vs placebo cycles.

In a recent meta-analysis, the prevalence of human papillomavirus, especially types 16 and 18, were significantly increased among patients with ovarian cancer vs controls.

A recent study suggests that postoperative endometriosis patients experience improved quality of life through hormone therapies guided by optimizing treatment based on individual hormonal receptor profiles.

In a recent study, only 22.7% of women had menopause symptoms documented in their electronic health record, highlighting low rates of diagnosis and treatment.

In a recent study, patients with early puberty had increased rates of diabetes, obesity, and other metabolic conditions, as well as increased mental health risks.